Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9

The anticancer properties of epigallocatechin-3-gallate (EGCG) are documented in the treatment of several types of cancer; however, there is no relevant evidence for its efficacy in the treatment of renal cell carcinoma (RCC). In the present study, the therapeutic effects of EGCG in vitro were inves...

Full description

Saved in:
Bibliographic Details
Published in:Exp Ther Med
Main Authors: CHEN, SHAO-JUN, YAO, XU-DONG, PENG, BO, XU, YUN-FEI, WANG, GUANG-CHUN, HUANG, JIANHUA, LIU, MIN, ZHENG, JUN-HUA
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2016
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4812156/
https://ncbi.nlm.nih.gov/pubmed/27073430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3050
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items